Trump, who was elected in 2016 with broad support from farmers,
signed the order in Iowa on June 11 and said it would speed up
reviews of biotechnology.
The National Pork Producers Council had hoped the order would relax
how the U.S. Food and Drug Association (FDA) regulates gene editing,
a technology that could be used to alter hogs to resist disease.
The agency "inaccurately classifies livestock as drugs and farms as
drug-manufacturing facilities," the council said in a statement.
However, the FDA told the council it thinks its approach to gene
editing is already in line with Trump's executive order, Andrew
Bailey, a lawyer for the pork group, told reporters on a conference
call.
The FDA told Reuters it is working to implement the order and wants
to avoid unnecessary barriers to innovation in plant and animal
biotechnology. The agency said it does not regulate animals as
drugs, but regulates intentional alterations to genomes in animals.
FDA regulation could lead to a lengthy and expensive process for
researchers and companies to gain U.S. approval for gene-edited
hogs, according to the National Pork Producers Council. That could
put the United States at risk of falling behind suppliers like
Canada, Brazil and China, the group said.
Unlike traditional genetically modified organisms, in which a gene
is added from another organism, gene editing works like the
find-and-replace function on a word processor. It finds a gene and
then makes changes by amending or deleting it.
[to top of second column] |
Scientists can edit genomes more precisely and rapidly than ever
before, and altered agricultural products could get to market more
quickly and cheaply.
The National Pork Producers Council wants the U.S. Department of
Agriculture rather than FDA to regulate gene editing in livestock.
Hog farmers globally are battling diseases like African swine fever
and Porcine Reproductive and Respiratory Syndrome that can kill
animals or increase the use of drugs in livestock.
Dan Kovich, deputy director of science and technology for the
council, said the FDA needs "to go back to the drawing board"
regarding its approach to gene editing.
Kovich said the pork lobby was working with the Trump administration
"to discuss ways to move forward and frankly make sure that the FDA
hears and understands our concerns."
(Reporting by Tom Polansek; Editing by Tom Brown and Leslie Adler)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|